A Critical and Comparative Study on Patient Information Leaflet, Primary Label and Primary Carton of a Carbapenem Dry Powder Injectable

@inproceedings{Tippavajhala2019ACA,
  title={A Critical and Comparative Study on Patient Information Leaflet, Primary Label and Primary Carton of a Carbapenem Dry Powder Injectable},
  author={Vamshi Krishna Tippavajhala and Lalit Kumar and Muddukrishna Badamane Sathyanarayana and Girish Thunga and Viji Chandran and Sohil Khan and Girish Pai Kulyadi},
  year={2019}
}
Introduction: The main aim of this project was to study the patient information leaflets (PIL), primary labels (PL) and primary cartons for their adequacy, harmonization of printed text matter meeting regulatory requirements. Methods: The study involved comparative evaluation of PIL, PL and primary cartons of generic and innovator brands. Three different marketed brands of Meropenem for Injection IP were considered for this research study which include the innovator product, coded as brand A… CONTINUE READING

Figures, Tables, and Topics from this paper.

References

Publications referenced by this paper.
SHOWING 1-10 OF 17 REFERENCES

meropenem for injection)

I. V. Merrem
  • Available from: https://www. accessdata.fda.gov/drugsatfda_docs/label/2008/050706s022lbl.pdf. Accessed on 02/02/2018
  • 2018

The Complete Drug Reference

Wisher D. Martindale
  • 37th edition
  • 2011

A descriptive study of the readability of patient information leaflets designed by nurses

ME Mumford
  • J Adv Nurs .
  • 2009

Patient information leaflets design and Readability

R Adepu, BG Nagavi
  • Pharma Rev
  • 2003